Skip to content
2000
Volume 5, Issue 1
  • ISSN: 2210-2965
  • E-ISSN: 2210-2973

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive motor neuron degeneration in the brain and spinal cord. Reliable treatment options for this disease are limited due to complexity and multifactorial causes of motor neuron damage. Cell therapy might be a promising treatment for ALS. Numerous preclinical studies have validated the feasibility of cell therapy using various cell types and routes of administration. These cell therapy approaches largely take one of two distinct therapeutic strategies: neuroprotection or motor neuron replacement. Despite some promising results, the success of cell therapy in ALS might rely on a combinative strategy that exploits the benefits of both neuronal cell protection and replacement. Although, ongoing clinical trials provide promising results in cell therapy for treatment of ALS patients, some challenges still facing potential cell therapy development. In this review, current cell products and patent technology related to cell therapeutic strategies are discussed. A detailed discussion of this topic might offer vital insight into the future and viability of cell therapy for ALS.

Loading

Article metrics loading...

/content/journals/rpgm/10.2174/2210309005666150506224404
2015-04-01
2025-06-04
Loading full text...

Full text loading...

/content/journals/rpgm/10.2174/2210309005666150506224404
Loading

  • Article Type:
    Research Article
Keyword(s): ALS; cell replacement; cell therapy; clinical trials; neuroprotection; patents
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test